| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $1.34B | $1.56B | $1.52B | $1.44B | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $252.40M | $245.10M | $215.97M | $202.10M | $190.47M |
| R&D | – | – | – | – | – |
| SG&A | $113.80M | $95.60M | $82.93M | $55.01M | $51.54M |
| Operating Income | $356.30M | $658.80M | $698.60M | $601.42M | $1.40M |
| Interest Expense | $74.40M | $74.10M | $60.86M | $48.79M | $42.38M |
| Tax Expense | $9.20M | -$2.00M | $4.04M | -$5.91M | $1.34M |
| Net Income | $286.00M | $611.50M | $647.97M | $562.57M | -$42.10M |
| EPS (basic) | 2.9100 | 6.5400 | 7.7500 | 6.9200 | -0.5400 |
| EPS (diluted) | 2.8500 | 6.3600 | 7.4800 | 6.8000 | -0.5400 |
| Shares (diluted) | $100.10M | $96.30M | $86.70M | $82.80M | $78.40M |